DCE-MRI
Showing 1 - 25 of 8,794
Brain Metastases, Glioma of Brain, Brain Tumor Trial in Los Angeles (Dynamic Contrast-Enhanced Magnetic Resonance Imaging,
Recruiting
- Brain Metastases
- +3 more
- Dynamic Contrast-Enhanced Magnetic Resonance Imaging
- Bevacizumab Injection
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
Nov 12, 2022
Hereditary Pancreatic Carcinoma, Pancreatic Adenocarcinoma, Pancreatic Intraductal Papillary-Mucinous Tumor Trial in Portland
Recruiting
- Hereditary Pancreatic Carcinoma
- +2 more
- Dynamic Contrast-Enhanced Magnetic Resonance Imaging
- Ferumoxytol
-
Portland, OregonOHSU Knight Cancer Institute
Aug 16, 2022
Glioblastoma Trial in Birmingham (Point-of-care Portable Perfusion Phantom (P4))
Recruiting
- Glioblastoma
- Point-of-care Portable Perfusion Phantom (P4)
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Jan 24, 2023
Childhood Brain Tumor, Recurrent Childhood Brain Tumor Trial in Portland (Dynamic Contrast-Enhanced Magnetic Resonance Imaging,
Completed
- Childhood Brain Neoplasm
- Recurrent Childhood Brain Neoplasm
- Dynamic Contrast-Enhanced Magnetic Resonance Imaging
- +3 more
-
Portland, OregonOHSU Knight Cancer Institute
Jul 11, 2022
Cervical Cancer Squamous Cell Trial in Toronto (18-FDG PET/CT, DWI, DCE-MRI)
Completed
- Cervical Cancer Squamous Cell
- 18-FDG PET/CT, DWI, DCE-MRI
-
Toronto, Ontario, CanadaUniversity Health Network, The Princess Margaret
Nov 7, 2022
Quantitative MRI Assessment of Breast Cancer Therapy Response
Recruiting
- Breast Cancer
- Diffusion Weighted Imaging
- Dynamic Contrast-Enhanced Magnetic Resonance Imaging
-
Iowa City, Iowa
- +2 more
Jan 19, 2023
Treatment of Abdominal Aortic Aneurysms
Recruiting
- Abdominal Aortic Aneurysm Without Rupture
- Magnetic resonance imaging (with PROUD software)
-
Amsterdam, Noord-Holland, NetherlandsAmsterdam UMC
Jul 26, 2023
Dynamic Contrast Enhanced MRI Diffusion Weighted MRI and
Active, not recruiting
- Head and Neck Cancer
- DCE-MRI, DW-MRI and MRS
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Mar 1, 2022
Squamous Cell Carcinoma of the Head and Neck Trial in Ann Arbor (Cisplatin, Carboplatin, IMRT (Intensity-Modulated Radiation
Active, not recruiting
- Squamous Cell Carcinoma of the Head and Neck
- Cisplatin
- +3 more
-
Ann Arbor, Michigan
- +1 more
Dec 20, 2022
StrokeCog-BBB to Study Cognitive Outcomes Following Stroke
Recruiting
- Stroke
- DCE-MRI
-
Palo Alto, CaliforniaStanford University Hospital
Oct 30, 2023
Neoadjuvant Chemotherapy in Breast Cancer Using Ultrafast
Recruiting
- Breast Cancer
- Response monitoring
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Feb 24, 2023
Breast Cancer, Triple Negative Breast Cancer Trial in New York (Sodium (Na) Magnetic Resonance Imaging (MRI), Dynamic Contrast-
Terminated
- Breast Cancer
- Triple Negative Breast Cancer
- Sodium (Na) Magnetic Resonance Imaging (MRI)
- Dynamic Contrast- Enhanced (DCE) MRI
-
New York, New YorkNYU Langone Health
Aug 1, 2022
Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer Trial in New Brunswick (Arterial Spin
Completed
- Stage I Renal Cell Cancer
- +3 more
- Arterial Spin Labeling Magnetic Resonance Imaging
- +3 more
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Oct 14, 2022
Estrogen Receptor Negative, HER2/Neu Negative, Progesterone Receptor Negative Trial in United States (procedure, other,
Active, not recruiting
- Estrogen Receptor Negative
- +3 more
- Dynamic Contrast-Enhanced Magnetic Resonance Imaging
- +3 more
-
Houston, Texas
- +5 more
Feb 11, 2022
Glioma, Pilocytic Astrocytoma, Anaplastic Astrocytoma Trial in Saint Louis (MRI-guided laser ablation, Doxorubicin, Etoposide)
Recruiting
- Glioma
- +8 more
- MRI-guided laser ablation
- +4 more
-
Saint Louis, MissouriWashington University School of Medicine
Jun 22, 2022
Prostate Cancer Trial in Philadelphia (motexafin gadolinium)
Active, not recruiting
- Prostate Cancer
- motexafin gadolinium
-
Philadelphia, PennsylvaniaHospital of the University of Pennsylvania
Oct 15, 2021
BCLC Stage A Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma Trial in
Recruiting
- BCLC Stage A Hepatocellular Carcinoma
- +3 more
- 18F-Fluoromisonidazole
- +3 more
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
May 25, 2022
Pancreatic Cancer Trial in Birmingham, Nashville (Point-of-care Portable Perfusion Phantom, P4)
Recruiting
- Pancreatic Cancer
- Point-of-care Portable Perfusion Phantom, P4
-
Birmingham, Alabama
- +1 more
Nov 3, 2022
Multiparametric MRI Based on Incoherent Undersampling
Active, not recruiting
- Pancreas Cancer
- multi-parametric MRI
-
Seoul, Korea, Republic ofSeoul National University Hospital
Dec 16, 2021
Cervical Cancer Trial in New York (Gadobutrol, MRI)
Recruiting
- Cervical Cancer
- Gadobutrol
- MRI
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Oct 6, 2021
MRI and PET Imaging in Predicting Treatment Response in Stage
Active, not recruiting
- Cervical Adenocarcinoma
- +12 more
- Computed Tomography
- +5 more
-
Miami, Florida
- +5 more
Oct 4, 2022
Predictive MRI Metrics for Tumor Aggressiveness in Papillary
Completed
- Papillary Thyroid Cancer
- diffusion weighted (DW) MRI
- dynamic contrast agent (DCE) MRI
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Dec 6, 2021
QSM and Regional DCE MRI Permeability Using GOCART Technique
Withdrawn
- Intracranial Neoplasm
- Dynamic Contrast-Enhanced Magnetic Resonance Imaging
- +3 more
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
Apr 1, 2021
18F-fluciclovine PET/MRI Imaging for Detection of Tumor
Suspended
- Metastatic Intracranial Malignant Neoplasm
- Recurrent Intracranial Neoplasm
- Dynamic Contrast-Enhanced Magnetic Resonance Imaging with Positron Emission Tomography
- Fluciclovine F18
-
Jacksonville, FloridaMayo Clinic in Florida
Dec 27, 2021
Metastatic Malignant Tumor in the Brain, Primary Brain Tumor Trial in Portland (3 Tesla Magnetic Resonance Imaging, Dynamic
Terminated
- Metastatic Malignant Neoplasm in the Brain
- Primary Brain Neoplasm
- 3 Tesla Magnetic Resonance Imaging
- +6 more
-
Portland, OregonOHSU Knight Cancer Institute
Nov 3, 2021